An official website of the United States government
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Sinclair A, Cimon K, Loncar M, et al. Dialysis Modalities for the Treatment of End-Stage Kidney Disease: A Health Technology Assessment [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Mar. (CADTH Optimal Use Report, No. 6.2b.)
| Strategy | Cost ($) | Incremental Cost ($) | QALYs | Incremental QALYs | ICUR ($/QALY) |
|---|---|---|---|---|---|
| ICHD | 637,101 | -reference- | 5.45 | -reference- | - |
| HHD (Cv) | 561,962 | −75,139 | 5.45 | 0 | Dominant |
| SDHHD | 617,983 | −19,117 | 5.45 | 0 | Dominant |
| NHHD | 617,983 | −19,117 | 5.45 | 0 | Dominant |
Cv = conventional; ICHD = in-centre conventional hemodialysis; ICUR = incremental cost-utility ratio; HHD = home hemodialysis; NHHD = nocturnal home hemodialysis; SDHHD = short-daily home hemodialysis; QALY = quality-adjusted life-year.
From: Economic Evaluation
Copyright © CADTH. This report may be reproduced for non-commercial purposes only and provided that appropriate credit is given to CADTH.
Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
Your browsing activity is empty.
Activity recording is turned off.
See more...
